About PreDxion Bio

PreDxion Bio is an early-stage healthcare company revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics. Enabled by PreDxion’s proprietary multiplexed localized surface plasmon resonance (LSPR) technology, our first product is a rapid, saliva-based test for COVID-19, flu, pneumonia, common cold, and other respiratory diseases.

Company Highlights
Year Founded

2017

icon-altEmployees

2

Location (HQ)

USA

Since Last Funding

3 years 12 months

Monthly Website Visitors

556.8K

icon-altTotal Investment Amt

$6.4M

Last Funding Round

Seed

icon-altYoY Headcount Growth

-32.26%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health

Wellness & Fitness

Wellness and Fitness Services

Biotechnology

Health Diagnostics

Medical Device